Chemed Corp: Form 10-Q for the period ended Sep 30, 2015
Filed with the SEC on Oct 30, 2015 and accepted by EDGAR at Oct 30, 2015, 08:16 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2015-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2015-07-01 to 2015-09-30 | $386.2m | us-gaap:SalesRevenueNet |
| Revenue | 9 months2015-01-01 to 2015-09-30 | $1.14bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2015-07-01 to 2015-09-30 | $272.1m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2015-01-01 to 2015-09-30 | $811.6m | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2015-07-01 to 2015-09-30 | $55.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2015-01-01 to 2015-09-30 | $171.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2015-07-01 to 2015-09-30 | $50.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2015-01-01 to 2015-09-30 | $135.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2015-07-01 to 2015-09-30 | $908.0k | us-gaap:InterestExpense |
| Interest expense | 9 months2015-01-01 to 2015-09-30 | $2.8m | us-gaap:InterestExpense |
| Income tax | 3 months2015-07-01 to 2015-09-30 | $18.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2015-01-01 to 2015-09-30 | $50.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2015-07-01 to 2015-09-30 | $28.8m | us-gaap:NetIncomeLoss |
| Net income | 9 months2015-01-01 to 2015-09-30 | $80.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2015-07-01 to 2015-09-30 | $1.65 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2015-01-01 to 2015-09-30 | $4.61 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2015-07-01 to 2015-09-30 | $1.71 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2015-01-01 to 2015-09-30 | $4.76 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2015-07-01 to 2015-09-30 | 17,422,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2015-01-01 to 2015-09-30 | 17,430,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2015-01-01 to 2015-09-30 | $113.1m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months2015-01-01 to 2015-09-30 | $30.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2015-01-01 to 2015-09-30 | $11.5m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2015-01-01 to 2015-09-30 | $36.7m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2015-09-30 | $38.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2015-09-30 | $200.8m | us-gaap:AssetsCurrent |
| Total assets | At period end2015-09-30 | $897.6m | us-gaap:Assets |
| Current liabilities | At period end2015-09-30 | $186.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2015-09-30 | $409.1m | us-gaap:Liabilities |
| Long-term debt | At period end2015-09-30 | $130.6m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2015-09-30 | $7.5m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2015-09-30 | $488.6m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2015-09-30 | 16,879,147 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001157523-15-003582. Last ingested by Listed: Oct 29, 2026, 09:14 ET. Listed shows no prices and gives no investment advice.